Roopa Industries Limited
BSE: ROOPAIND
Prev Close
57.37
Open Price
55.99
Volume
779
Today Low / High
52.5 / 55.99
52 WK Low / High
47.26 / 86.34
Range
52 - 57
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 54.29, reflecting a change of -3.08 (-5.36866%). The expected target range on the BSE is 52 - 57. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Roopa Industries Limited Graph
Roopa Industries Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Roopa Industries Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 54.29, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 54.29 | 54.83 | 49.35 - 60.32 |
| 55.38 | 44.30 - 66.45 | ||
| 55.92 | 39.14 - 72.69 | ||
| Bearish Scenario | 54.29 | 53.75 | 48.37 - 59.12 |
| 53.20 | 42.56 - 63.85 | ||
| 52.66 | 36.86 - 68.46 |
Overview of Roopa Industries Limited
ISIN
INE443C01010
Industry
Medical - Pharmaceuticals
Vol.Avg
2,599
Market Cap
414,198,283
Last Dividend
0
Official Website
IPO Date
DCF Diff
-131.44
DCF
198
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 120.69 Cr | 113.85 Cr | 6.84 Cr | 0.0567 | 0.00 Cr | 0.00 Cr | 3.26 Cr | 2.03 Cr | 2.60 | 6.41 Cr | 0.0169 |
| 2024-03-31 | 71.55 Cr | 64.26 Cr | 7.30 Cr | 0.1020 | 0.00 Cr | 0.00 Cr | 4.81 Cr | 1.52 Cr | 1.95 | 5.57 Cr | 0.0212 |
| 2023-03-31 | 75.89 Cr | 61.99 Cr | 13.90 Cr | 0.1832 | 0.00 Cr | 0.30 Cr | 3.39 Cr | 1.35 Cr | 1.72 | 4.54 Cr | 0.0178 |
| 2022-03-31 | 51.21 Cr | 40.32 Cr | 10.89 Cr | 0.2127 | 0.00 Cr | 0.29 Cr | 2.58 Cr | 1.02 Cr | 1.29 | 3.50 Cr | 0.0198 |
| 2021-03-31 | 28.44 Cr | 17.68 Cr | 10.77 Cr | 0.3785 | 0.00 Cr | 0.27 Cr | -0.10 Cr | 0.72 Cr | 0.91 | 2.62 Cr | 0.0252 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.62 Cr | 76.46 Cr | 58.96 Cr | 17.4944 Cr | 33.27 Cr | 28.65 Cr | 36.15 Cr | 8.81 Cr | 0.00 Cr | 0.00 Cr | 0.02 Cr | 50.7512 Cr |
| 2024-03-31 | 2.98 Cr | 64.68 Cr | 49.21 Cr | 15.4734 Cr | 25.75 Cr | 22.77 Cr | 25.16 Cr | 9.62 Cr | 0.00 Cr | 0.00 Cr | 0.02 Cr | 42.5601 Cr |
| 2023-03-31 | 1.95 Cr | 56.55 Cr | 42.61 Cr | 13.9430 Cr | 18.87 Cr | 16.93 Cr | 18.38 Cr | 10.86 Cr | 0.67 Cr | 0.45 Cr | 3.25 Cr | 39.5854 Cr |
| 2022-03-31 | 1.49 Cr | 49.02 Cr | 36.44 Cr | 12.5844 Cr | 11.97 Cr | 10.48 Cr | 15.34 Cr | 10.38 Cr | 0.62 Cr | 0.00 Cr | 0.01 Cr | 31.0305 Cr |
| 2021-03-31 | 0.50 Cr | 46.33 Cr | 34.77 Cr | 11.5646 Cr | 13.46 Cr | 12.96 Cr | 19.46 Cr | 10.46 Cr | 0.27 Cr | 0.40 Cr | 0.35 Cr | 25.6097 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -13.1183 Cr | -0.0577 Cr | 13.5803 Cr | -13.9706 Cr | 0.0000 Cr | 4.6219 Cr | -0.8523 Cr | 2.0349 Cr | 13.6032 Cr | 0.0000 Cr | -10.9849 Cr |
| 2024-03-31 | -0.9677 Cr | 1.1131 Cr | 3.2041 Cr | 3.8279 Cr | 1.1389 Cr | 3.0841 Cr | 0.0000 Cr | 1.5191 Cr | 4.0273 Cr | 0.0000 Cr | 0.0000 Cr |
| 2023-03-31 | 8.9114 Cr | -0.9874 Cr | -7.4707 Cr | 7.5400 Cr | 0.4533 Cr | 1.9452 Cr | -1.3714 Cr | 1.8067 Cr | -5.9921 Cr | 0.0000 Cr | -3.0370 Cr |
| 2022-03-31 | 2.3445 Cr | 3.6533 Cr | -5.0075 Cr | 1.5019 Cr | 0.9903 Cr | 1.4919 Cr | -0.8426 Cr | 1.3603 Cr | -3.7242 Cr | 0.0000 Cr | 4.1158 Cr |
| 2021-03-31 | -0.5151 Cr | 1.3369 Cr | -0.5754 Cr | -1.2572 Cr | 0.2464 Cr | 0.5016 Cr | -0.7421 Cr | 0.9325 Cr | 0.2185 Cr | 0.0000 Cr | -7.1045 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 29.83 Cr | 28.72 Cr | 1.11 Cr | 0.0372 | 0.25 Cr | 0.42 Cr | 0.53 | 1.58 Cr | 0.0140 |
| 2024-12-31 | 30.73 Cr | 28.05 Cr | 2.68 Cr | 0.0872 | 0.71 Cr | 0.76 Cr | 0.97 | 1.89 Cr | 0.0247 |
| 2024-09-30 | 25.61 Cr | 22.32 Cr | 3.29 Cr | 0.1286 | 1.44 Cr | 0.58 Cr | 0.74 | 1.64 Cr | 0.0228 |
| 2024-06-30 | 34.51 Cr | 32.52 Cr | 1.99 Cr | 0.0576 | 0.85 Cr | 0.27 Cr | 0.35 | 1.29 Cr | 0.0079 |
| 2024-03-31 | 22.08 Cr | 19.68 Cr | 2.40 Cr | 0.1089 | 0.73 Cr | 0.46 Cr | 0.59 | 1.63 Cr | 0.0206 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.62 Cr | 0.00 Cr | 4.62 Cr | 13.00 Cr | 36.15 Cr | 67.28 Cr | 8.81 Cr | 76.46 Cr | 58.96 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 4.82 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -16.33 Cr |
| 2024-09-30 | 3.66 Cr | 1.17 Cr | 4.82 Cr | 0.00 Cr | 23.93 Cr | 59.58 Cr | 9.05 Cr | 76.86 Cr | 60.53 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 4.25 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -15.47 Cr |
| 2024-03-31 | 2.98 Cr | 1.17 Cr | 4.15 Cr | 8.24 Cr | 25.16 Cr | 48.64 Cr | 9.62 Cr | 64.68 Cr | 49.21 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.76 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.27 Cr | 0.45 Cr | 0.00 Cr | 0.00 Cr | 0.45 Cr | 3.67 Cr | 3.21 Cr | 0.00 Cr | 0.45 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹804.05 | ₹96,279,696,851.00 | ₹756,659.00 |
Key Executives
Gender: male
Year Born: 1956
Gender: male
Year Born: 1954
Gender: female
Year Born:
Gender: male
Year Born:
FAQs about Roopa Industries Limited
The CEO is Tumbalam Gooty Raghavendra.
The current price is ₹52.66.
The range is ₹47.26-86.34.
The market capitalization is ₹41.42 crores.
The P/E ratio is 20.29.
The company operates in the Healthcare sector.
Overview of Roopa Industries Limited (ISIN: INE443C01010) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹41.42 crores and an average daily volume of 2,599 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.